Results 251 to 260 of about 1,479,789 (367)

Two or three cycles of induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma? [PDF]

BMC Cancer
Guo LF, Yu YF, Lu ZZ, Lin Q, Wu SG.
europepmc   +1 more source

Heterogeneity Landscape of Circulating Tumor Cells in Clinical Utility

Advanced Therapeutics, Volume 8, Issue 10, October 2025.
This study reports the heterogeneity spectrum of circulating tumor cells. The factors involved in the spectrum promote CTCs to overcome barriers in the metastatic cascade but impact the clinical outcome of cancer patients. In summary, the heterogeneities in association with CTCs ultimately reduce patient survival and facilitate increasing mortality of ...
Md Kowsar Alam, Lu Yanjun, Bee Luan Khoo, Tongxu Si, Heng Zou, Mengsu Yang   +5 more
wiley   +1 more source

Characterization of the Antibody Response to the Latent Infection Terminal Proteins of Epstein-Barr Virus in Patients with Nasopharyngeal Carcinoma

, 1993
Barbara Frech, Ursula Zimber‐Strobl, Timothy T. C. Yip, W.H. Lau, Anja Müeller   +4 more
openalex   +1 more source

The TET3/GATA6 Axis Drives Lipid Metabolism and Therapeutic Vulnerabilities in Pancreatic Ductal Adenocarcinoma

Advanced Science, Volume 12, Issue 37, October 6, 2025.
The DNA demethylase TET3 drives lipid metabolic reprogramming in pancreatic ductal adenocarcinoma via a non‐catalytic mechanism. TET3 recruits histone deacetylases to repress GATA6, sustaining lipogenic enzyme expression and ferroptosis resistance.
Shuai Liu, Shaobo Kang, Na Lin, Wenqi Zhang, Shiwen Wang, Yuqing Ren, Xiaofan Ding, Jianxiu Yu, Ruiyu Xie   +8 more
wiley   +1 more source

The FOXD1/NAT10 positive feedback loop drives nasopharyngeal carcinoma progression. [PDF]

Hereditas
Liu L, Chen Q, Li Y, Wu W, Jiang F, Qiu H.   +5 more
europepmc   +1 more source

Cardiovascular Disease Meets Cancer: Exploring the Epidemiology in China and Homotherapy Targeting Intersectional Mechanisms

Advanced Science, Volume 12, Issue 37, October 6, 2025.
Cardiovascular disease (CVD) and cancer are leading causes of death worldwide, with overlapping risk factors and pathophysiological mechanisms. This review explores shared pathways, including metabolic dysregulation, chronic inflammation, and gut microbiome alterations, highlighting dual‐benefit strategies such as lifestyle modifications and repurposed
Shihan Xiang, Yujie Shan, Shihong Xu, Jing Wang, Meng Luo, Jiaojiao Zhou, Qishan Chen   +6 more
wiley   +1 more source

A dataset of primary nasopharyngeal carcinoma MRI with multi-modalities segmentation. [PDF]

Sci Data
Li Y, Chen Q, Li M, Si L, Guo Y, Xiong Y, Wang Q, Qin Y, Xu L, Smagt PV, Wang K, Tang J, Chen N.   +12 more
europepmc   +1 more source

Radiotherapy for nasopharyngeal carcinoma: shielding the pituitary may improve therapeutic ratio

, 1993
Jonathan S. T. Sham, Damon Choy, Philip Kwong, C.C. Yau, Kai-fung Wan, Ashley Cheng   +5 more
openalex   +1 more source

Non-dietary risk factors for nasopharyngeal carcinoma in Shanghai, China [PDF]

, 2000
Jian‐Min Yuan, Xueli Wang, Yong‐Bing Xiang, Yu‐Tang Gao, Ronald K. Ross, Mimi C. Yu   +5 more
openalex   +1 more source

SenExo‐cCCT2 Reprograms Senescence Response and Anti‐Tumor Immunity Following FOLFIRINOX Chemotherapy in Pancreatic Ductal Adenocarcinoma

Advanced Science, Volume 12, Issue 38, October 13, 2025.
This study demonstrates that SenExo‐cCCT2 enables targeted delivery of cCCT2 to pancreatic cancer cells, where it disrupts IPO13‐mediated nuclear translocation of UBC9, impairing SUMOylation‐dependent DNA damage repair and inducing senescence. Senescent tumor cells secrete CXCL10 to recruit CD8⁺ T‐cells while upregulating PD‐L1.
Shuncang Zhu, Yinhao Chen, Hongyi Lin, Jinpeng Lu, Yu Pan, Ge Li, Yongding Wu, Haoxiang Zhang, Xiaoxiao Huang, Yiting Chen, Huangjing Chen, Long Jin, Min Huang, Chengyu Liao, Long Huang, Yifeng Tian, Zuwei Wang, Qiaowei Li, Shi Chen   +18 more
wiley   +1 more source